Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| NKA-M52H5 | Mouse | Mouse NKG2A / CD159a Protein, His Tag |  |
|
|
| NKA-C5245 | Cynomolgus | Cynomolgus NKG2A / CD159a Protein, His Tag |  |
|
|
| NKA-H526c | Human | Human NKG2A / CD159a Protein, Fc Tag |  |
|
|
| NKA-H5244 | Human | Human NKG2A / CD159a Protein, His Tag |  |
|
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Monalizumab | NNC-0141-0000-0100; NNC 0141-0000-0100; IPH-22XX; IPH-22; NN-8765; IPH-2201 | Phase 3 Clinical | Novo Nordisk A/S | Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Carcinoma, Non-Small-Cell Lung; Mouth Neoplasms; Esophageal adenocarcinoma; Inflammation; Carcinoma, Squamous Cell; Esophageal Squamous Cell Carcinoma; Genital Neoplasms, Female; Colorectal Neoplasms; Head and Neck Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Transitional Cell; Arthritis, Rheumatoid; Small Cell Lung Carcinoma; Stomach Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Hematologic Neoplasms; Solid tumours | Details |
| BMS-986315 | BMS-986315 | Phase 2 Clinical | Bristol-Myers Squibb Company | Solid tumours; Carcinoma, Non-Small-Cell Lung | Details |
| S-095029 | S-095029 | Phase 2 Clinical | Institut De Recherches Internationales Servier | Solid tumours; Mismatch Repair Deficient Cancer; Stomach Neoplasms; Esophageal Neoplasms; Microsatellite instability-high cancer; Carcinoma, Non-Small-Cell Lung | Details |
| BRY-805 | BRY805; BRY-805 | Phase 1 Clinical | Hisun Biopharmaceutical Co Ltd, BioRay Pharmaceutical Co Ltd | Solid tumours | Details |
| HY000102 | HY-0102; HY-000102 | Phase 1 Clinical | Shanghai HyaMab Biotech Co Ltd | Solid tumours; Pancreatic Neoplasms | Details |
This web search service is supported by Google Inc.
A-Z
